HER 2 Win
7 October 2022 webinar
President: Paolo Marchetti
In the last year the HER2 positive disease has undergone to a real revolution.
The landscape has been radically changed with the advent of new therapeutic strategies.
The knowledge of the biological mechanisms underlying this tumour type plays a crucial role to identify the best therapeutic path for cancer patients.
In this course, opinion leaders provide a moment of scientific development and constructive dialogue able to ensure an event of high impact.